Alecensa 150 mg

Alecensa 150 mg is a medicine authorised by Swissmedic under authorisation number 65970. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 January 2017 and the authorisation is valid without a time limit. ATC code L01ED03 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 65970
ATC L01ED03
Synthetic medicines

Authorisation data
Authorisation number	65970
Name	Alecensa 150 mg
Full name	Alecensa 150 mg, Hartkapseln
Authorisation holder	Roche Pharma (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01ED03
First authorisation	26 January 2017
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Alecensa 150 mg, Hartkapseln	A	26 January 2017

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	224	Kapsel(n)	L01ED03	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

Actemra 162 mg/0.9 mlAuthorisation number 63166 · ATC L04AC07A Actemra 162 mg/0.9 mlAuthorisation number 66931 · ATC L04AC07A Actemra 80 mg/4 mlAuthorisation number 58868 · ATC L04AC07A Avastin 100 mg/4 mlAuthorisation number 56922 · ATC L01FG01A CellceptAuthorisation number 54701 · ATC L04AA06B Cellcept 250 mgAuthorisation number 53337 · ATC L04AA06B Cellcept 500 mgAuthorisation number 53338 · ATC L04AA06B Cellcept i.v.Authorisation number 54688 · ATC L04AA06B

Frequently asked questions

Is Alecensa 150 mg authorised in Switzerland?

Yes. Alecensa 150 mg is authorised by Swissmedic under authorisation number 65970, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Alecensa 150 mg have?

Alecensa 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Alecensa 150 mg?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.